Randomised controlled trial of tyrosine supplementation on neuropsychological performance in phenylketonuria

Archives of Disease in Childhood

Volumn 78, Issue 2, 1998, Pages 116-121

  Smith, Mary Lou ^a,b   Hanley, William B ^a   Clarke, Joe T R ^a   Klim, Paula ^a   Schoonheyt, Wanda ^a   Austin, Valerie ^a   Lehotay, Denis C ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Frontal lobe function; Phenylalanine; Phenylketonuria; Tyrosine

Indexed keywords

PHENYLALANINE; TYROSINE;

ADOLESCENT; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; HUMAN; MEMORY; METABOLIC ENCEPHALOPATHY; NEUROPSYCHOLOGY; ORAL DRUG ADMINISTRATION; PHENYLKETONURIA; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0031919577     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.78.2.116     Document Type: Article

References (47)

1. Berry HK, Bofinger MK, O'Grady DJ, Perlmutter LJ. Intellectual development and academic achievement of children treated early for phenylketonuria. Dev Med Child Neural 1979;21:311-20.
2. Koch R, Azen C, Friedman EG, Williamson ML. Paired comparison between early treated phenylketonuria children and their matched sibling controls on intellectual and school achievement test results at eight years. J Inherit Metab Dis 1984;7:86-90.
3. Smith I, Beasley MG, Ades AE. Intelligence and quality of dietary treatment in phenylketonuria. Arch Dis Child 1990; 65:472-8.
4. Brunner RL, Jordan MK, Berry HK. Early-treated phenylketonuria: neuropsychologic consequences. J Pediatr 1983;102:831-5.
5. Cabalska B, Duszynska N, Borzymowska J, Zorska K, Koslacz-Folga A, Bozkowa K. Termination of dietary treatment in phenylketonuria. Eur J Pediatr 1977;126:253-62.
6. Clarke JTR, Gates RD, Hogan SE, Barrett M, MacDonald GW. Neuropsychological studies on adolescents with phenylketonuria returned to phenylalanine-restricted diets. Am J Ment Retard 1987;92:255-62.
7. Crowie VA Neurological and psychiatric aspects of phenylketonuria. In: Bickel H, Hudson F, Woolf L, eds. Phenylketonuria and some inborn errors of amino acid metabolism. Stuttgart: Springer, 1971.
8. Krause W, Halminski M, McDonald L, et al. Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. J Clin Invest 1985;75:40-8.
9. Pennington BF, Van Doorninck WJ, McCabe LL, McCabe ERB. Neuropsychological deficits in early treated phenylketonuric children. Am J Ment Def 1985;89:467-74.
10. Ris MR, Williams SE, Hunt MM, Berry HK, Leslie N. Early-treated phenylketonuria: adult neuropsychologic outcome. J Pediatr 1994;124:388-92.
11. Seashore MR, Friedman E, Novelly RA, Bapat V. Loss of intellectual function in children with phenylketonuria after relaxation of dietary phenylalanine restriction. Pediatrics 1985;75:226-32.
12. Smith I, Beasley MG, Wolff OH, Ades AE. Behavior disturbance in eight year old children with phenylketonuria. J Pediatr 1988;112:403-8.
13. Smith I, Beasley MG. Intelligence and behavior in children with early treated phenylketonuria. Eur J Clin Nutr 1989;S43:1-5.
14. Smith ML, Klim P, Mallozzi E, Hanley WB. A test of the frontal specificity hypothesis in the cognitive performance of adults with Phenylketonuria. Dev Neuropsychol 1996:12: 327-41.
15. Welsh MC, Pennington BF, Ozonoff S, Rouse B, McCabe ERB. Neuropsychology of early-treated phenylketonuria: specific executive function deficits. Child Dev 1990;61: 1697-713.
16. Kaufam S. The phenylalanine hydroxylating system from mammalian liver. Adv Enzymol 1969;35:245-319.
17. Murray JE. Carrier-mediated transfer of amino acids from blood to brain. Neurology 1973;23:940-4.
18. Snodgrass SR, Cutler RWP, Kang ES, Lorenzo AV. Transport of neutral amino acids from feline cerebrospinal fluid. Am J Physiol 1969;217:974-80.
19. Guroff G, King W, Udenfriend S. The uptake of tyrosine by rat brain in vitro. J Biol Chem 1961;236:1773-7.
20. Neame KD. Phenylalanine as inhibitor of transport of amino acids in brain. Nature 1961;192:173-4.
21. Oldendorf WH. Saturation of blood brain barrier transport of amino acids in phenylketonuria. Arch Neurol 1973;28:45-8.
22. Knudsen GM, Hasselbalch S, Toft PB, Christensen E, Paul-son OB, Lou H. Blood-brain barrier transport of amino acids in healthy controls and in patients with phenylketonuria. J Inher Metab Dis 1995;18:653-64.
23. Christensen HN. Where do the depleted amino acids go in phenylketonuria? Biochem J 1986;326:929-30.
24. Nord AM, McCabe L, McCabe ERB. Biochemical and nutritional status of children with hyperphenylalaninaemia. J Inher Metab Dis 1988;11:431-2.
25. McKean CM. The effect of high phenylalanine concentration on serotonin and catecholamine metabolism in the human brain. Brain Res 1972;47:469-76.
26. Lou HC, Guttler F, Lykkelund C, Bruhn P, Niederwieser A. Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents. Eur J Pediatr 1985;144:17-20.
27. Bessman SP. The justification theory: the essential nature of the non-essential amino acids. Nutr Rev 1979;37:209-20.
28. Lou HC, Lykkelund C, Gerdes AM, Udesen H, Bruhn P. Increased vigilance and dopamine synthesis by large doses of tyrosine or phenylalanine restriction in phenylketonuria. Acta Paediatr Scand 1987;76:560-5.
29. Lykkelund C, Nielson JB, Lou HC, et al. Increased neurotransmitter biosynthesis in phenylketonuria induced by phenylalanine restriction or by supplementation of unrestricted diet with large amounts of tyrosine. Eur J Pediatr 1989;148:239-45.
30. Mazzocco MMM, Yannicelli S, Nord AM, Van Doorninck W, Davidson-Mundt AJ, Greene CL. Cognition and tyrosine supplementation among school-aged children with phenylketonuria. Am J Dis Child 1992;146:1261-4.
31. Pietz J, Landwehr R, Kutscha A, Schmidt H, de Sonneville L, Trefz FK. Effect of high-dose tyrosine supplementation on brain function in adults with phenylketonuria. J Pediatr 1995;127:936-43.
32. Diamond A. Phenylalanine levels of 6-10 mg/dl may not be as benign as once thought. Acta Pediatr Scand suppl 1994;407:89-91.
33. Diamond A, Ciaramitaro V, Donner E, Dhali S, Robinson MB. An animal model of early-treated phenylketonuria. J Neurosci 1994;14:3072-82.
34. Weglage J, Pietsch M, Funders B, Koch HG, Ullrich K. Deficits in selective and sustained attention processes in early treated children with phenylketonuria - result of impaired frontal lobe functions. Eur J Pediatr 1996;155: 200-4.
35. Becker MG, Isaac W, Hynd GW. Neuropsychological development of non-verbal behaviors attributed to "frontal lobe" functioning. Dev Neuropsychol 1988;3:275-98.
36. Passler MA, Isaac W, Hynd GW. Neuropsychological development of behavior attributed to frontal lobe functioning in children. Dev Neuropsychol 1985;1:349-70.
37. Shue KL, Douglas VI. Attention deficit hyperactivity disorder and the frontal lobe syndrome. Brain Cogn 1992;20: 104-24.
38. Gordon M, Mettelman B. The assessment of attention. I. Standardization and reliability of a behavior-based measure. J Clin Psychol 1988;44:682-90.
39. Rosvold H, Mirsky A, Sarason I, Beck A. A continuous performance test of brain damage. J Consult Psychol 1956;20: 343-52.
40. Petrides M, Milner B. Deficits on subject ordered tasks after frontal-and temporal-lobe lesions in man. Neuropsychologia 1982;20:249-62.
41. Christensen AL. Luria's neuropsychological invstigation. New York: Spectrum, 1975.
42. Brown J. Some tests of the decay theory of immediate memory. Q J Exp Psychol 1958;10:12-21.
43. Peterson LR, Peterson MJ. Short-term retention of individual verbal items. J Exp Psychol 1959;58:193-8.
44. Hannay JH, Levin HS. Selective reminding test: an examination of the equivalence of four forms. J Clin Exp Neuropsychol 1985;7:251-63.
45. Dunn LM, Dunn LM. Peabody picture vocabulary test-revised manual. Circle Pines, MN: American Guidance Service, 1981.
46. Glaeser BS, Melamed E, Growdon JH, Wurtman RJ. Elevation of plasma tyrosine after a single dose of L-tyrosine. Life Sci 1979;25:265-71.
47. Waisbren SE, Schnell R, Levy HL. Intelligence and personality characteristics in adults with untreated atypical phenylketonuria and mild hyperphenylalaninemia. J Pediatr 1984;105:955-8.